基于抗体的治疗方法用于高胆固醇血清症
1Faculty of Medicine, Macau University of Science & Technology, Macau, 999078, People's Republic of China.
Biologics : targets & therapy
|November 3, 2025
概括
针对PCSK9,ANGPTL3和ANGPTL4的单克隆抗体,在他类药物失败时为高胆固醇血症提供了新的治疗方法. 这些先进疗法可降低高危患者的LDL胆固醇和心血管风险.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 类药物和ezetimibe是高胆固醇血症的第一线治疗方法,但往往不足以达到低密度脂蛋白 (LDL) 胆固醇的目标.
- 尽管使用标准口服疗法,但LDL胆固醇不受控制的患者仍然存在残留心血管风险.
研究的目的:
- 审查开发用于解决与不受控制的LDL胆固醇相关的残留心血管风险的单克隆抗体 (mAbs).
- 讨论针对PCSK9,ANGPTL3和ANGPTL4的新型mAbs,用于高胆固醇血症的管理.
主要方法:
- 关于用于高胆固醇血症治疗的单克隆抗体的科学文献的综述.
- 对PCSK9,ANGPTL3和ANGPTL4抑制剂的疗效和安全数据的分析.
主要成果:
- PCSK9抑制剂 (alirocumab,evolocumab) 对高风险患者有效且安全,但无法达到LDL目标.
- 在中国批准的较新的PCSK9 mAbs提供较少的剂量.
- 埃维纳库马布 (ANGPTL3 抑制剂) 已批准用于同卵性家族性高胆固醇血症;其他 ANGPTL3 和 ANGPTL4 mAbs 正在开发中.
结论:
- 单克隆抗体在治疗高胆固醇血症和降低心血管风险方面取得了重大进展.
- 新兴的疗法,如反感性寡核酸和小干扰RNA,可能会提供更具成本效益的替代方案.
- 需要进行进一步的研究,以确定新型mAbs.的长期疗效和更广泛的指示.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Hybridoma Technology
17.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.2K
Coronary Artery Disease V: Interprofessional Care
208
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
208
Antibody Actions
2.3K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
2.3K


